Skip to content
10-Q

Quarterly Report

MEDTOX SCIENTIFIC INC

0000739944-11-000029

← back to feed
Filed
Jul 28, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Jul 14, 2011 8.92M sh
Total Liabilities Q2 2011 · Jun 30, 2011 $16.09M
Total Liabilities Q2 2011 · Dec 31, 2010 $13.91M
Current Assets Q2 2011 · Jun 30, 2011 $30.36M
Current Assets Q2 2011 · Dec 31, 2010 $30.06M
Total Assets Q2 2011 · Jun 30, 2011 $76.38M
Total Assets Q2 2011 · Dec 31, 2010 $75.46M
Shares Diluted Q2 2011 · Jun 30, 2010 8.96M sh
Shares Diluted Q2 2011 · Jun 30, 2010 8.91M sh
Capex Q2 2011 · Jun 30, 2010 $2.41M
Operating Cash Flow Q2 2011 · Jun 30, 2010 $3.11M
Cash And Equivalents Q2 2011 · Jun 30, 2010 $4.95M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $4.17M
Eps Diluted Q2 2011 · Jun 30, 2010 $0.11
Eps Diluted Q2 2011 · Jun 30, 2010 $0.12
Eps Basic Q2 2011 · Jun 30, 2010 $0.12
Eps Basic Q2 2011 · Jun 30, 2010 $0.13
Sga Expense Q2 2011 · Jun 30, 2010 $8.23M
Sga Expense Q2 2011 · Jun 30, 2010 $15.66M
Rd Expense Q2 2011 · Jun 30, 2010 $573K
Rd Expense Q2 2011 · Jun 30, 2010 $1.12M
Operating Income Q2 2011 · Jun 30, 2010 $1.54M
Operating Income Q2 2011 · Jun 30, 2010 $1.66M
Gross Profit Q2 2011 · Jun 30, 2010 $10.34M
Gross Profit Q2 2011 · Jun 30, 2010 $18.44M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $14.84M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $27.91M
Revenue Q2 2011 · Jun 30, 2010 $25.19M
Revenue Q2 2011 · Jun 30, 2010 $46.35M